CannabisNewsBreaks

MondayOct 08, 2018 1:51 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Strengthens IP Portfolio

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) is building its strategic intellectual property (“IP”) portfolio with two recent Notices of Allowance from the U.S. Patent and Trademark Office (“USPTO”) as well as the addition of three new patents in Australia. The company anticipates receiving additional patents in the U.S. by the end of the year. An article discussing Lexaria reads, “If all are issued, LXRP will then hold 12 issued patents within its first patent family, “Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof.” It would strengthen LXRP’s IP claims in both countries. All new…

Continue Reading

FridayOct 05, 2018 1:38 pm

CannabisNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Quickly Progresses Into a Global Strategic Growth Platform

Canopy Rivers (TSX.V: RIV) (OTC: CNPOF), a unique investment and operating platform, has quickly advanced from its roots and recently began trading on the TSX Venture Exchange. The company was originally founded to diversify Canopy Growth Corp.’s (TSX: WEED) (NYSE: CGC) cannabis supply streams. A recent article discussing the company reads: “The Company is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. The Company works collaboratively with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. The Company has developed an investment ecosystem of complementary cannabis operating companies that…

Continue Reading

FridayOct 05, 2018 11:01 am

CannabisNewsBreaks – Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Raising Funds through Sale of Units

Sunniva (CSE: SNN) (OTCQX: SNNVF) recently revealed its intention to raise C$20 million through the sale of units of the company to a syndicate of underwriters, detailed in a company press release (http://cnw.fm/ZMw2T). The terms of the sale are an amendment of a previously announced agreement to sell 1.9 million units. An article discussing the company’s plan reads, “Sunniva announced that the syndicate will purchase 3.8 million units priced at C$5.27 per unit, an amendment of the previously publicized agreement which said that the syndicate was to buy 1.9 million units. Subject to the approval of the Canadian Securities Exchange,…

Continue Reading

ThursdayOct 04, 2018 11:02 am

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Enters LOI to Acquire Penta 5 Group, Extensive Portfolio of Market-Ready Products

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) late Wednesday announced its entry into a letter of intent with Penta 5 Packaging Inc. and Penta 5 USA, LLC (together the “Penta 5 Group”) through which PreveCeutical intends to acquire the Penta 5 Group and its assets, including over 120 market-ready products and a 150,000-square-foot, state-of-the-art packaging facility. “The Transaction will significantly benefit PreveCeutical and its shareholders,” Stephen Van Deventer, chairman, CEO and president of PreveCeutical, stated in the news release. “The Penta 5 Group, led by R. Charles Murray, has recorded over 20 years of success…

Continue Reading

ThursdayOct 04, 2018 10:51 am

CannabisNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Grants Incentive Stock Options; Names New Executive Team Member

The Flowr Corporation (TSX.V: FLWR), a vertically integrated Canadian cannabis company, has appointed Francesco Tallarico as general counsel and corporate secretary, effective October 1, 2018. David Miller, who served as the company’s corporate secretary before Tallarico joined the Flowr team, will remain on the company’s Board of Directors. "I am very pleased to welcome Francesco to the Flowr executive management team," Flowr CEO Vinay Tolia stated in the news release. "He is an exceptional leader and lawyer and brings a wealth of experience that we expect will prove instrumental as we continue to execute on our strategic goals." In addition,…

Continue Reading

WednesdayOct 03, 2018 3:23 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Extends List of Applicable Uses for Innovative Drug Delivery Platform

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) continues to leverage its drug delivery platform technology in exciting new markets. An article discussing the company reads, “It has patents granted in the U.S. and Australia for applications of its DehydraTECH™ technology. Moreover, the company has many patents pending in over 40 nations. Lexaria Bioscience’s business strategy involves expanding the applicability of its technology within and beyond the cannabinoid sector. Recently upgraded to the OTC Markets’ OTCQX Best Market, Lexaria Bioscience is based in Kelowna, British Columbia. … The DehydraTECH™ drug delivery platform promotes healthier ingestion methods. It considerably improves the body’s ability…

Continue Reading

WednesdayOct 03, 2018 1:05 pm

CannabisNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Gears Up to Target Two Key Canadian Markets through New Brand Licensing Deal

The Flowr Corporation (TSX.V: FLWR), a vertically integrated Canadian cannabis company, was the subject of an article published by TheGlobeandMail.com today, titled ‘Cannabis Professional: Ace Hill, Flowr blaze the branding trail with licensing deal’ authored by Mark Rendell. As noted in the article, a first for the Canadian cannabis industry was reached today through the execution of a brand licensing deal by Toronto craft brewer Ace Hill and FLWR. The companies have partnered up to market a line of pre-rolled joints in Ontario and British Columbia. Per the article, FLWR will grow, package and ship two cannabis strains that will then…

Continue Reading

WednesdayOct 03, 2018 11:10 am

CannabisNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Enters Strategic Partnership with Ace Valley Cannabis Brand

The Flowr Corporation (TSX.V: FLWR), a Canadian cultivator of premium cannabis, this morning announced a strategic partnership with Ace Valley, a new brand of cannabis products targeted at the upcoming Canadian adult-use recreational market. Per the update, Ace Valley’s curated product portfolio of pre-rolled joints and premium dried flower applies the deep understanding of consumer values and trends held by the team behind Ace Hill Beer to the cannabis market, while also leveraging Flowr’s expertise in cultivation. “From the start, Flowr and Ace Valley shared a commitment to creating high quality, authentic products for customers,” Steve Klein, chairman and chief…

Continue Reading

WednesdayOct 03, 2018 9:41 am

CannabisNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investee Company Receives $9.6M Purchase Order

FinCanna Capital (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, this morning announced that its investee company, Refined Resin Technologies Inc., has attained its second purchase order for THC distillate in the minimum amount of $9.6 million, bringing its total purchase orders to $10.4 million. The order was received from a prominent, large volume, California cannabis enterprise and specifies $9.6 million as a minimum annual amount, contingent to consistent delivery and performance. “This multimillion-dollar order from an industry leading distributor illustrates the outstanding reputation and confidence in the Refined Resin team from leading players…

Continue Reading

TuesdayOct 02, 2018 11:20 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Successfully Closes Acquisition of HemPoland

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) this morning announced the closing and approval from the Toronto Stock Exchange of its acquisition of HemPoland. In connection with the transaction, the company has paid $7.75 million in cash and has issued 1,968,323 restricted shares that will be escrowed for a term of three years from closing. There is also a contingent consideration of up to 3,047,722 deferred shares based on HemPoland achieving $32 million in EBITDA for the financial year 2021. TGOD will invest an additional $10.3 million in HemPoland to fund innovative product…

Continue Reading